Showing results (31-40 of 203) with videos related to
Sort By:
Pageof 21
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndromeC Y Spong, D T Abebe, I Gozes, et al.The Journal of Clinical Investigation|November 1, 1994
Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouseP Gressens, J M Hill, B Paindaveine, et al.Annals of the New York Academy of Sciences|December 26, 1996
VIP regulation of embryonic growthJ M Hill, S K McCune, R J Alvero, et al.The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptidesD E Brenneman, J Hauser, E Neale, et al.Journal of Neurochemistry|December 3, 1999
Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced deathG W Glazner, A Boland, A E Dresse, et al.Brain Research|January 20, 1992
Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonistJ R Glowa, L V Panlilio, D E Brenneman, et al.Journal of Molecular Neuroscience : MN|January 1, 1994
Inhibition of human neuroblastoma growth by a specific VIP antagonistG Lilling, Y Wollman, M N Goldstein, et al.Endocrinology|July 19, 2001
IGF-I as a mediator of VIP/activity-dependent neurotrophic factor-stimulated embryonic growthS J Servoss, S J Lee, G Gibney, et al.Annals of the New York Academy of Sciences|February 24, 2001
A novel VIP responsive gene. Activity dependent neuroprotective proteinI Gozes, R Zamostiano, A Pinhasov, et al.Cancer|October 12, 2001
A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell linesE Gelber, R Granoth, M Fridkin, et al.Pageof 21